Current theranostics for neurodegenerative diseases (NDD) management are majorly symptomatic due to a lack of identification of early-stage biomarkers and the inefficiency of drugs to penetrate through the blood-brain barrier. Recently. the Neuro-nanotechnology interface has emerged as a potential strategy for diagnosis. monitoring. https://parisnaturalfoodes.shop/product-category/potat/